Advaxis Canine Cancer Vaccine Featured on ABC News
November 22, 2013 at 08:47 AM EST
Advaxis (NASDAQ: ADXS ) announced that ADXS-cHER2, its proprietary immunotherapy for the treatment of breast cancer and canine osteosarcoma, was featured on ABC News in an article titled “Bone